Targeting JNK pathway promotes human hematopoietic stem cell expansion

Area of Science:

• Stem Cell Biology
• Hematopoiesis
• Molecular Signaling

Background:

• Limited numbers of human hematopoietic stem cells (HSCs) hinder clinical use.
• In vitro HSC expansion is challenging due to poorly understood self-renewal mechanisms.
• Signaling pathways regulating HSC self-renewal require further elucidation.

Purpose of the Study:

• To investigate the role of the JNK signaling pathway in human HSC self-renewal.
• To identify strategies for enhancing in vitro expansion of HSCs.
• To assess the functional capacity of expanded HSCs for clinical relevance.

Main Methods:

• Culturing human cord blood CD34+ cells with JNK-IN-8, a JNK pathway inhibitor.
• Assessing HSC self-renewal and expansion capacity.
• Evaluating long-term repopulation and secondary engraftment in recipient mice.
• Utilizing c-Jun knockdown to further investigate the JNK pathway's role.

Main Results:

• JNK-IN-8 treatment resulted in a 3.88-fold increase in HSC cell number.
• Cultured CD34+ cells showed sustained repopulation (21 weeks) and secondary engraftment in mice.
• Knockdown of c-Jun, a JNK target, promoted hematopoietic stem and progenitor cell (HSPC) expansion.

Conclusions:

• The JNK signaling pathway critically regulates HSC expansion and self-renewal.
• Targeting the JNK pathway offers a promising strategy for enhancing HSC expansion.
• Findings provide insights into HSC self-renewal mechanisms, potentially improving HSC-based therapies.